G35. Demyelinating diseases of the central nervous system
Conditions
Interventions
Intervention 1: Group test: 4 sessions over 4 weeks (1 session per week) with each session lasting 30 minutes for patients in the intervention group (the number of sessions may be added if necessary).
Behavior
Treatment - Drugs
Group test: 4 sessions over 4 weeks (1 session per week) with each session lasting 30 minutes for patients in the intervention group (the number of sessions may be added if necessary). The booklet and
The control group: received usual care and research tools will be given to them.
Sponsors
Vice chancellor for Research Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: a definite diagnosis of MS by a neurologist ability to read and write; ability to participate in training sessions; negative history of any exacerbation of the disease over the past three months; not being pregnant; not changing the dose of drugs in use; the absence of chronic cardiopulmonary diseases and psychological disorders . Exclusion criteria: admission to hospital or recurrence of the disease; not attending at least one teaching session; developing a progressive type of MS; having excessive fatigue that makes the patient unable to receive the training; serious medical conditions.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Coping. Timepoint: The first day and a month after the last training session. Method of measurement: questionnaire.;Self management. Timepoint: The first day and a month after the last training session. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShima Parnian
Iran University of Medical Sciences
Outcome results
None listed